BACKGROUND & AIMS
The incidences of decompensated cirrhosis (defined by ascites, hepatic encephalopathy, or bleeding esophageal varices), hepatocellular carcinoma (HCC), and liver-related mortality… (More)
Administration of interferon (IFN) 3 times weekly in patients with chronic hepatitis C (CHC) is associated with low sustained responses, which may be, in part, related to this regimen's inability to… (More)
UNLABELLED
The ability to predict which patients are most likely to achieve a sustained virologic response (SVR) with peginterferon/ribavirin would be useful in optimizing treatment for hepatitis C… (More)
BACKGROUND
Protease inhibitors have improved treatment of infection with hepatitis C virus (HCV), but dosing, a low barrier to resistance, drug interactions, and side-effects restrict their use. We… (More)
OBJECTIVE
To evaluate the outcome after initial non-operative treatment in patients with small bowel obstruction (SBO).
DESIGN
Prospective study.
SETTING
University hospital, Norway.
PATIENTS… (More)
BACKGROUND
Non-alcoholic fatty liver disease (NAFLD) patients with elevated serum alanine aminotransferase (ALT) generally undergo a liver biopsy to evaluate for possible non-alcoholic… (More)
In order to determine whether or not regular exercise could alter myocardial perfusion or function, we randomized 146 male volunteers with stable coronary heart disease to either a supervised… (More)
UNLABELLED
Mericitabine is a nucleoside analog polymerase inhibitor of hepatitis C virus (HCV). Treatment-naïve HCV genotype 1 or 4 patients were randomized to double-blind treatment with oral… (More)
O ver 180 million people are infected with hepatitis C virus (HCV) worldwide. Despite significant advances in therapy, an alarmingly high number of patents remain both undiagnosed and untreated.… (More)